These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1625 related items for PubMed ID: 7554977

  • 1. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B, Zeng T, Wu S, Sun H, Xiao N.
    Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
    [Abstract] [Full Text] [Related]

  • 2. Ovarian function after seven years' use of a levonorgestrel IUD.
    Barbosa I, Olsson SE, Odlind V, Goncalves T, Coutinho E.
    Adv Contracept; 1995 Jun; 11(2):85-95. PubMed ID: 7491859
    [Abstract] [Full Text] [Related]

  • 3. Ovarian function during use of a levonorgestrel-releasing IUD.
    Barbosa I, Bakos O, Olsson SE, Odlind V, Johansson ED.
    Contraception; 1990 Jul; 42(1):51-66. PubMed ID: 2117516
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
    Heikinheimo O, Gordon K, Williams RF, Hodgen GD.
    Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ultrasonographic and endocrine evaluation of ovarian function among Norplant implants users with regular menses.
    Alvarez F, Brache V, Faundes A, Tejada AS, Thevenin F.
    Contraception; 1996 Nov; 54(5):275-9. PubMed ID: 8934060
    [Abstract] [Full Text] [Related]

  • 7. Effects of a sequential regimen of mifepristone-medroxyprogesterone acetate on ovarian function, endometrial development and hormonal parameters.
    Croxatto HB, Massai MR, Salvatierra AM, Fuentealba B, Croxatto HD, Lähteenmäki P.
    Contraception; 1996 Aug; 54(2):79-86. PubMed ID: 8842583
    [Abstract] [Full Text] [Related]

  • 8. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
    Pakarinen PI, Suvisaari J, Luukkainen T, Lähteenmäki P.
    Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T, Toivonen J.
    Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
    [Abstract] [Full Text] [Related]

  • 11. Effects of a single contraceptive Silastic implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years.
    Barbosa I, Coutinho E, Hirsch C, Ladipo O, Olsson SE, Ulmsten U.
    Fertil Steril; 1996 Apr; 65(4):724-9. PubMed ID: 8654629
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A morphometric study on the endometrial activity of women before and after one year with LNG-IUD in situ.
    Gu Z, Zhu P, Luo H, Zhu X, Zhang G, Wu S.
    Contraception; 1995 Jul; 52(1):57-61. PubMed ID: 8521716
    [Abstract] [Full Text] [Related]

  • 14. Hormonal intrauterine devices.
    Rybo G, Andersson K, Odlind V.
    Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
    [Abstract] [Full Text] [Related]

  • 15. Lipid effects of an intrauterine levonorgestrel device or oral vs. vaginal natural progesterone in post-menopausal women treated with percutaneous estradiol.
    Suvanto-Luukkonen E, Sundström H, Penttinen J, Kauppila A.
    Arch Gynecol Obstet; 1998 Apr; 261(4):201-8. PubMed ID: 9789651
    [Abstract] [Full Text] [Related]

  • 16. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
    Suvisaari J, Lähteenmäki P.
    Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
    [Abstract] [Full Text] [Related]

  • 17. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D, Antoniou G, Karakitsos P, Kalogirou O, Antoniou D, Giannikos L.
    Int J Fertil Menopausal Stud; 1996 Oct; 41(6):522-7. PubMed ID: 9010746
    [Abstract] [Full Text] [Related]

  • 18. Morphometric study of the human endometrium following continuous exposure to levonorgestrel released from vaginal rings during 90 days.
    Johannisson E, Brosens I, Cornillie F, Elder M, White J, Sheppard B, Hourihan H, d'Arcangues C, Belsey EM.
    Contraception; 1991 Apr; 43(4):361-74. PubMed ID: 1906792
    [Abstract] [Full Text] [Related]

  • 19. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK, Kirkman RJ, Arce BB, McNeilly AS, Loudon NB, Baird DT.
    Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
    [Abstract] [Full Text] [Related]

  • 20. Plasma levonorgestrel levels and ovarian function during the use of a levonorgestrel-releasing intracervical contraceptive device.
    Ratsula K, Toivonen J, Lähteenmäki P, Luukkainen T.
    Contraception; 1989 Feb; 39(2):195-204. PubMed ID: 2495893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 82.